3D at Depth Expands US Operations and Opens New Location in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
3D at Depth Expands US Operations and Opens New Location in Perth, Australia

BOULDER, Colo., June 17, 2015 (GLOBE NEWSWIRE) -- 3D at Depth (3D), a global provider of advanced subsea LiDAR systems and solutions, announced today the official opening of a new office in Perth, Australia. Under the name of 3D at Depth, Asia Pacific PTY LTD; the new location will support the company's current Asia Pacific customer base and help cultivate new opportunities in the region. The new office will be managed by Mr. Adam Lowry, who brings a wealth of industry hydrographic experience to the team. Mr. Lowry'sleadership and project management skills include prior work for Fugro, Australia, and Seabed Geosolutions (A Fugro/CGG Joint Venture). He was also formerly the lead author for the search for MH370 tender and was a project manager for specific aspects of the program. As Managing Director – Asia Pacific, Lowry will facilitate the growth strategy for the region and focus on serving the offshore oil and gas, exploration and production market.

In addition to the new Australian location, the company has expanded manufacturing and production operations through a 5,500 sq. ft. facility located in the Boulder, Colorado headquarters, while maintaining its original 2,500 sq. ft. facility within the same business park. The state-of-the-art facility will allow the design, manufacturing, measurement and assembly of all sensors in one location for better quality and process control. In addition, the new plant has a lab environment outfitted with a class 1000 optical clean room, a 40 ft. test tank and a variety of measurement, assembly and manufacturing tools. The consolidation of engineering, design and manufacturing into one location will leverage in-house expertise across the production and delivery value chain for greater innovation and efficiency.

"Our LiDAR systems and solutions are built around trying to solve the challenges of subsea data collection and imaging survey programs. Using LiDAR over other 3D imaging methods such as acoustic or optical measurement methods greatly increases the speed, repeatability and resolution. We develop our solutions to help clients build and maintain their underwater assets in a more efficient, safe and an environmentally friendly manner." States 3D CEO, Carl Embry. "With our new office in the Asia Pacific region and under Adam's guidance we can focus our sales efforts in the region and broaden our service business lines to better serve our current clients."

3D at Depth was founded in 2009, using LiDAR sensor technology to address data collection challenges (in terms of range, accuracy, field of view, depth, and integration) faced by the subsea construction, survey and inspection industry. With the SL1 & SL2 and the integration of software and hardware, the 3D LiDAR platform now services oil and gas, commercial, government and defense markets through the world. Subsea LiDAR solutions are proving to be cost effective, have better accuracy, and are reducing the cost of survey and vessel time.

About 3D at Depth:

Founded in 2009, provides advanced subsea LiDAR systems and solutions designed to help clients build, maintain, map and monitor underwater assets and resources. The 3D at Depth LiDAR platform consists of integrated hardware and software technology developed to address the challenges of subsea data collection and survey applications for oil and gas, commercial, government and defense industries.

For more information: www.3datdepth.com

Colleen Hahn (703) 851-6944

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles